Prior to joining Johnson & Johnson, Marc Leibowitz spent nearly two decades in tech, both as an entrepreneur and inside organizations such as StumbleUpon, Dropbox, and Google. He made the switch to healthcare to “make the world a better place,” which he adds “is the sort of audacious ambition that’s motivated me throughout my career.”

He is motivated by the opportunity digital presents to help people be well. This includes avoiding getting sick in the first place, or perhaps better managing a chronic condition. “The incumbent regulations, incentives, and reimbursement infrastructure are much less robust in wellcare, which allow for more experimentation and innovation,” says Leibowitz.

He leads J&J’s digital transformation agenda, health tech strategy, and go-to-market activities — spanning programs, products, partnerships, investments, acquisitions, and joint ventures — across the organization’s three worldwide business units: consumer, pharma, and device. “My responsibilities include partnering with commercial and R&D leaders to transform how health and wellcare is delivered, managed, and experienced, as well as exploring ‘white space’ opportunities to blend science and tech in ways that have potential to impact human health and wellness at scale,” he explains.

“Digital at J&J is about embracing a user needs-centered mindset and an iterative, data-driven approach to prioritization and problem-solving so we can accelerate the velocity at which we bring life-enhancing, if not life-saving, solutions to the world.”

And yet Leibowitz also senses an urgency for the company, and pharma at large, to adapt to the digital age, which includes hiring talent from the outside, giving them the runway to experiment, and learning a new way to work. This is highly strategic and touches every aspect of the business. He notes it requires “critically assessing established methodology around decision-making, funding, hiring, space-planning, goal-setting, and compensation, and asking how these processes can be made more user-centric and efficient. From a strategic standpoint, I’m always thinking about how we can operationalize ideas and bring them to life.”